PFW Advisors’s AbbVie ABBV Stock Holding History

PFW Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+870	New	+$187K	0.06%	117
2025 Q4	–	Sell	-983	Closed	-$228K	–	122
2025 Q3	$228K	Buy	+983	New	+$200K	0.07%	119
2025 Q2	–	Sell	-1,221	Closed	-$256K	–	126
2025 Q1	$256K	Hold	1,221	–	–	0.08%	104
2024 Q4	$217K	Buy	+1,221	New	+$224K	0.07%	115
2024 Q2	$206K	Sell	1,200 -194	-14%	-$32.1K	0.07%	114
2024 Q1	$254K	Buy	1,394 +39	+3%	+$6.72K	0.08%	109
2023 Q4	$210K	Buy	+1,355	New	+$198K	0.07%	114
2019 Q3	$241K	Buy	+1,219	New	+$83.6K	0.07%	108

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFW Advisors's ABBV Position: Q2 2026 in Review

PFW Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 870 shares worth $219K. The stake represents 0.06% of the portfolio and ranks #117 among its holdings. This is a return to the name: PFW Advisors previously reported a position in ABBV as recently as Q3 2025.

PFW Advisors first reported a position in ABBV in Q3 2019 and has held it in 8 quarters since. The position peaked at $256K in Q1 2025. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PFW Advisors held 870 shares of AbbVie worth $219K as of Q2 2026.
AbbVie was a new PFW Advisors position in Q2 2026.
AbbVie made up 0.06% of PFW Advisors's portfolio in Q2 2026, its #117 holding.
PFW Advisors first reported a position in AbbVie in Q3 2019 and has held it in 8 quarters since.
PFW Advisors's AbbVie position peaked at $256K in Q1 2025.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PFW Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.